Direct Modulation of Host Cells and Gut Microbiota by Orally Delivered Antioxidant Nanocages for Colitis Treatment
ACS Nano · 2025
DOI: 10.1021/acsnano.5c08006 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Jingwen Xie und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University,…. Hauptthemen laut MEDLINE: Antioxidants, Gastrointestinal Microbiome, Colitis, Ulcerative, Colitis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Zhejiang University, National Key Research and Development Program of China, Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Ulcerative colitis (UC) involves a complex interplay of mucosal inflammation, intestinal barrier dysfunction, and gut dysbiosis, all exacerbated by elevated reactive oxygen species (ROS). Existing therapies often fail to concurrently address these interrelated pathologies. Here we present an orally administrable nanocage system that targets both host cells and gut microbiota and can simultaneously address immune dysregulation, epithelial damage, and microbial imbalances for UC treatment when loaded with antioxidant enzymes. This system features a poly(tertiary amine oxide) (PTAO)-based zwitterionic shell and ROS-labile cross-linkers around individual protein molecules. This structure provides robust cargo protection and retention during gastrointestinal transit and enables ROS-triggered release at inflamed sites. Upon internalization by intestinal epithelial cells and macrophages, the nanocages can be directed to mitochondria for efficient ROS scavenging, which promotes epithelial repair and macrophage repolarization. Moreover, the PTAO shell provides bacterial permeability that allows direct enzyme delivery into gut microbes, thus protecting them from oxidative damage and restoring microbial balance. In mouse models of UC and acute radiation colitis, this multifunctional system effectively alleviated inflammation, restored gut homeostasis, and reduced colonic damage, demonstrating its promising therapeutic potential for colitis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, Zhejiang 310058, China.
- Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
ORCID-Profile: Jiajia Xiang, Shiqun Shao, Youqing Shen
Förderung
- Zhejiang University
- National Key Research and Development Program of China
- Medical Science and Technology Project of Zhejiang Province
- Key Research and Development Program of Zhejiang Province
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Xie, J., Si, J., Chen, Y., Ding, H., Cao, Y., Xiang, J., Shao, S., & Shen, Y. (2025). Direct Modulation of Host Cells and Gut Microbiota by Orally Delivered Antioxidant Nanocages for Colitis Treatment. ACS Nano. https://doi.org/10.1021/acsnano.5c08006
Vancouver
Xie J, Si J, Chen Y, Ding H, Cao Y, Xiang J, et al. Direct Modulation of Host Cells and Gut Microbiota by Orally Delivered Antioxidant Nanocages for Colitis Treatment. ACS Nano. 2025. doi:10.1021/acsnano.5c08006
BibTeX
@article{Xie2025,
author = {Xie, Jingwen and Si, Jingxing and Chen, Yuping and Ding, Hanchen and Cao, Yangyang and Xiang, Jiajia and Shao, Shiqun and Shen, Youqing},
title = {Direct Modulation of Host Cells and Gut Microbiota by Orally Delivered Antioxidant Nanocages for Colitis Treatment},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.5c08006}
}
EUVIMED